Erin Maynard
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Transplantation top 10%
Papers in
- Co-authors
- Michael F. Daily (8 shared papers)Roberto Gedaly (8 shared papers)Malay B. Shah (9 shared papers)Ching‐Wei D. Tzeng (7 shared papers)Brett T. Spear (2 shared papers)William C. Chapman (3 shared papers)Yiing Lin (3 shared papers)Neeta Vachharajani (3 shared papers)
- Journals
- HPB (9 papers)Journal of the American College of Surgeons (4 papers)Journal of Gastrointestinal Surgery (3 papers)Journal of Surgical Oncology (2 papers)American Journal of Transplantation (2 papers)
- Partner nations
- United StatesChinaBahrain
In The Last Decade
Erin Maynard
37 papers receiving 574 citations
Peers
Comparison fields: 5 of 52
- Hepatology 206
- Transplantation 21
- Oncology 150
- Surgery 215
- Cancer Research 63
Countries citing papers authored by Erin Maynard
This map shows the geographic impact of Erin Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Maynard more than expected).
Fields of papers citing papers by Erin Maynard
This network shows the impact of papers produced by Erin Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Maynard. The network helps show where Erin Maynard may publish in the future.
Co-authors
The 25 scholars most cited alongside Erin Maynard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 100 | |
| 2 | 2016 | 79 | |
| 3 | 2013 | 74 | |
| 4 | Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways. | 2014 | 62 |
| 5 | 2012 | 47 | |
| 6 | 2012 | 30 | |
| 7 | 2015 | 19 | |
| 8 | 2014 | 18 | |
| 9 | 2016 | 17 | |
| 10 | 2016 | 17 | |
| 11 | 2015 | 13 | |
| 12 | 2021 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2019 | 10 | |
| 15 | 2018 | 9 | |
| 16 | 2016 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2017 | 5 |
About Erin Maynard
Erin Maynard is a scholar working on Surgery, Oncology, Hepatology, Public Health, Environmental and Occupational Health and Epidemiology, having authored 41 papers that have together received 587 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Organ Transplantation Techniques and Outcomes (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Liver Disease and Transplantation (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Organ Donation and Transplantation (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Hepatology (206 citations), Transplantation (21 citations), Oncology (150 citations), Surgery (215 citations) and Cancer Research (63 citations). Erin Maynard has collaborated with scholars based in United States, China and Bahrain. Frequent co-authors include Michael F. Daily, Roberto Gedaly, Malay B. Shah, Ching‐Wei D. Tzeng, Brett T. Spear, William C. Chapman, Yiing Lin, Neeta Vachharajani, Surendra Shenoy and Majella M.B. Doyle. Their work appears in journals such as HPB, Journal of the American College of Surgeons, Journal of Gastrointestinal Surgery, Journal of Surgical Oncology and American Journal of Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.